Rockefeller Capital Management
TGTX icon

Rockefeller Capital Management’s TG Therapeutics TGTX Stock Holding History

Rockefeller Capital Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$244K Sell
4,444
-2,877
-39% -$118K ﹤0.01% 2496
2026
Q1 		$243K Sell
7,321
-15,737
-68% -$469K ﹤0.01% 2376
2025
Q4 		$687K Buy
23,058
+5,292
+30% +$173K ﹤0.01% 1736
2025
Q3 		$642K Buy
17,766
+6,090
+52% +$201K ﹤0.01% 1646
2025
Q2 		$420K Buy
+11,676
New +$435K ﹤0.01% 1597
2023
Q3 		– Sell
-21
Closed -$541 – 1805
2023
Q2 		$541 Sell
21
-26,016
-100% -$672K ﹤0.01% 1804
2023
Q1 		$391K Buy
26,037
+25,000
+2,411% +$380K ﹤0.01% 1458
2022
Q4 		$12K Buy
1,037
+700
+208% +$5.08K ﹤0.01% 3016
2022
Q3 		$1K Buy
337
+21
+7% +$138 ﹤0.01% 3789
2022
Q2 		$1K Hold
316
– – ﹤0.01% 4018
2022
Q1 		$3K Sell
316
-1
-0.3% -$12 ﹤0.01% 3530
2021
Q4 		$6K Sell
317
-1,983
-86% -$51.5K ﹤0.01% 3217
2021
Q3 		$76K Sell
2,300
-45
-2% -$1.39K ﹤0.01% 1980
2021
Q2 		$90K Buy
2,345
+45
+2% +$1.77K ﹤0.01% 1841
2021
Q1 		$110K Buy
2,300
+1,000
+77% +$48K ﹤0.01% 1555
2020
Q4 		$67K Buy
1,300
+300
+30% +$10.1K ﹤0.01% 1583
2020
Q3 		$26K Buy
+1,000
New +$23K ﹤0.01% 1703

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Rockefeller Capital Management's TGTX Position: Q2 2026 in Review

Rockefeller Capital Management reduced its TG Therapeutics (TGTX) stake by 39% in Q2 2026, selling an estimated $118K and leaving 4,444 shares worth $244K. The position accounts for ﹤0.01% of the portfolio, ranked #2496.

Rockefeller Capital Management first reported a position in TGTX in Q3 2020 and has held it in 17 quarters since. The position peaked at $687K in Q4 2025. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Rockefeller Capital Management held 4,444 shares of TG Therapeutics worth $244K as of Q2 2026.
  • Rockefeller Capital Management sold 2,877 TG Therapeutics shares in Q2 2026, an estimated $118K.
  • TG Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2496 holding.
  • Rockefeller Capital Management first reported a position in TG Therapeutics in Q3 2020 and has held it in 17 quarters since.
  • Rockefeller Capital Management's TG Therapeutics position peaked at $687K in Q4 2025.
  • 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.